What We're Reading: Page 8
Industry reads hand-picked by our editors
Mar 16, 2026
Mar 13, 2026
Mar 12, 2026
-
La Lettre
Biotech Abivax gives AstraZeneca exclusive period to position itself for takeover
-
Axios
The cloud over the FDA has not yet lifted, despite controversial official’s exit
-
Nature
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
-
The New York Times
A Third of Americans Have Cut Spending or Borrowed Money for Health Care
Mar 11, 2026
-
Stat
A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback
-
Bloomberg
Vinay Prasad’s Exit From FDA Offers Relief — Not Resolution
-
Endpoints
Lundbeck CEO talks drug pricing, protecting biotech and how Europe needs to ‘step up’
-
MIT Technology Review
Peptides are everywhere. Here’s what you need to know.
Mar 10, 2026
Mar 09, 2026
Mar 06, 2026
-
The Wall Street Journal
Federal Health Officials Attack Rare-Disease Drug, Say Company Lied
-
The Washington Post
The U.S. can’t afford to offshore clinical trials to China
-
San Francisco Business Journal
GSK reached out to buyout target’s big shareholder before talking to senior leaders
Previous
